1. PI3K/Akt/mTOR
  2. PI3K
  3. IHMT-PI3K-455

IHMT-PI3K-455 (Compound 15u) 是一种有效,选择性和具有口服活性的 PI3Kγ/δ 双重抑制剂。IHMT-PI3K-455 对 PI3KγPI3KδIC50 分别为 7.1 nM 和 0.57 nM。IHMT-PI3K-455 抑制了 AKT 磷酸化。IHMT-PI3K-455 通过招募和激活更多 CD8+ 杀伤 T 细胞抑制肿瘤生长。IHMT-PI3K-455 可用于肿瘤研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

我们将采用定制合成服务的方式为您快速提供所需产品和技术服务

IHMT-PI3K-455 Chemical Structure

IHMT-PI3K-455 Chemical Structure

CAS No. : 3047746-40-4

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

IHMT-PI3K-455 (Compound 15u) is a potent, selective, orally active PI3Kγ/δ dual inhibitor with IC50s of 7.1 nM and 0.57 nM for PI3Kγ and PI3Kδ, respectively. IHMT-PI3K-455 suppresses the AKT phosphorylation. IHMT-PI3K-455 inhibits tumor growth by recruiting and activating more CD8+ killing T cells.IHMT-PI3K-455 is used in cancer research[1].

IC50 & Target

PI3Kα

6.717 μM (IC50)

PI3Kβ

42.04 nM (IC50)

PI3Kγ

7.1 nM (IC50)

PI3Kδ

0.57 nM (IC50)

体外研究
(In Vitro)

IHMT-PI3K-455 (1 μM,2 小时) 抑制了 RAW264.7 和 Raji 细胞中 PI3Kγ/δ 介导的 AKT 磷酸化[1]
IHMT-PI3K-455 (1 μM,72 小时) 改变由 THP-1 和 BMDM 细胞衍生的 M2 巨噬细胞的极化[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Differentiation Assay[1]

Cell Line: Macrophages
Concentration: 0.1, 1 μM
Incubation Time: 72 h
Result: Increased the proinflammatory M1 macrophage phenotype in a dose-dependent manner, with a concomitant dose-dependent decrease of the anti-inflammatory M2 macrophage phenotype.
Repolarized M2 phenotype toward M1 phenotype in THP-1 and BMDM macrophages.

Western Blot Analysis[1]

Cell Line: RAW264.7 cells; Raji cells
Concentration: 0, 0.01, 0.03, 0.1, 0.3, 1 μM
Incubation Time: 2 h
Result: Potently inhibited the PI3Kγ-mediated AKT473 phosphorylation in RAW264.7 cells (human C5a stimulation) with an IC50 value of 0.015 μM.
Potently inhibited the PI3Kδ-mediated AKT473 phosphorylation in Raji cells (anti-IgM stimulation) with an IC50 value of 0.010 μM.
体内研究
(In Vivo)

IHMT-PI3K-455 (40 mg/kg,口服;一天一次,连用 30 天) 抑制了 MC38 肿瘤异种移植模型中的肿瘤生长[1]
IHMT-PI3K-455 (40 mg/kg,口服;一天一次,连用 30 天) 通过招募和激活更多 CD8+ 杀伤 T 细胞抑制肿瘤生长[1]
Pharmacokinetic parameters of IHMT-PI3K-455 in Sprague-Dawley rats[1]

Dose (mg/kg) Administration route Cmax (ng/mL) Tmax (h) AUC0-∞ (h ng/mL) T1/2 (h) CL (L/h/kg) Vz (L/kg) F (%)
1 i.v. 1233 0.03 477 1.59 2.12 4.80 -
10 p.o. 157 3.42 838 2.71 14.76 56.02 17.6

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: MC38 tumor model[1]
Dosage: 10 mg/kg, 40 mg/kg
Administration: Oral gavage (p.o.); Once daily for 30 days
Result: Significantly inhibited tumor size in a dose-dependent manner.
Increased tumor-infiltrating CD8+T cells.
分子量

517.49

Formula

C26H21F2N7O3

CAS 号
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
IHMT-PI3K-455
目录号:
HY-149493
需求量: